scholarly journals CrowdDetective: Wisdom of the Crowds for Detecting Abnormalities in Medical Scans

10.36850/rga1 ◽  
2020 ◽  
Vol 1 (1) ◽  
pp. 59-71 ◽  
Author(s):  
Veronika Cheplygina

Machine learning (ML) has great potential for early diagnosis of disease from medical scans, and at times, has even been shown to outperform experts. However, ML algorithms need large amounts of annotated data – scans with outlined abnormalities - for good performance. The time-consuming annotation process limits the progress of ML in this field. To address the annotation problem, multiple instance learning (MIL) algorithms were proposed, which learn from scans that have been diagnosed, but not annotated in detail. Unfortunately, these algorithms are not good enough at predicting where the abnormalities are located, which is important for diagnosis and prognosis of disease. This limits the application of these algorithms in research and in clinical practice. I propose to use the “wisdom of the crowds” –internet users without specific expertise – to improve the predictions of the algorithms. While the crowd does not have experience with medical imaging, recent studies and pilot data I collected show they can still provide useful information about the images, for example by saying whether images are visually similar or not. Such information has not been leveraged before in medical imaging applications. I will validate these methods on three challenging detection tasks in chest computed tomography, histopathology images, and endoscopy video. Understanding how the crowd can contribute to applications that typically require expert knowledge will allow harnessing the potential of large unannotated sets of data, training more reliable algorithms, and ultimately paving the way towards using ML algorithms in clinical practice.

2020 ◽  
Vol 48 (5) ◽  
pp. 2295-2305
Author(s):  
Jiawei Zhang ◽  
Dandan Li ◽  
Rui Zhang ◽  
Peng Gao ◽  
Rongxue Peng ◽  
...  

The role of miR-21 in the pathogenesis of various liver diseases, together with the possibility of detecting microRNA in the circulation, makes miR-21 a potential biomarker for noninvasive detection. In this review, we summarize the potential utility of extracellular miR-21 in the clinical management of hepatic disease patients and compared it with the current clinical practice. MiR-21 shows screening and prognostic value for liver cancer. In liver cirrhosis, miR-21 may serve as a biomarker for the differentiating diagnosis and prognosis. MiR-21 is also a potential biomarker for the severity of hepatitis. We elucidate the disease condition under which miR-21 testing can reach the expected performance. Though miR-21 is a key regulator of liver diseases, microRNAs coordinate with each other in the complex regulatory network. As a result, the performance of miR-21 is better when combined with other microRNAs or classical biomarkers under certain clinical circumstances.


2021 ◽  
Vol 22 (11) ◽  
pp. 6091
Author(s):  
Kristina Daniunaite ◽  
Arnas Bakavicius ◽  
Kristina Zukauskaite ◽  
Ieva Rauluseviciute ◽  
Juozas Rimantas Lazutka ◽  
...  

The molecular diversity of prostate cancer (PCa) has been demonstrated by recent genome-wide studies, proposing a significant number of different molecular markers. However, only a few of them have been transferred into clinical practice so far. The present study aimed to identify and validate novel DNA methylation biomarkers for PCa diagnosis and prognosis. Microarray-based methylome data of well-characterized cancerous and noncancerous prostate tissue (NPT) pairs was used for the initial screening. Ten protein-coding genes were selected for validation in a set of 151 PCa, 51 NPT, as well as 17 benign prostatic hyperplasia samples. The Prostate Cancer Dataset (PRAD) of The Cancer Genome Atlas (TCGA) was utilized for independent validation of our findings. Methylation frequencies of ADAMTS12, CCDC181, FILIP1L, NAALAD2, PRKCB, and ZMIZ1 were up to 91% in our study. PCa specific methylation of ADAMTS12, CCDC181, NAALAD2, and PRKCB was demonstrated by qualitative and quantitative means (all p < 0.05). In agreement with PRAD, promoter methylation of these four genes was associated with the transcript down-regulation in the Lithuanian cohort (all p < 0.05). Methylation of ADAMTS12, NAALAD2, and PRKCB was independently predictive for biochemical disease recurrence, while NAALAD2 and PRKCB increased the prognostic power of multivariate models (all p < 0.01). The present study identified methylation of ADAMTS12, NAALAD2, and PRKCB as novel diagnostic and prognostic PCa biomarkers that might guide treatment decisions in clinical practice.


2020 ◽  
Vol 83 (6) ◽  
pp. AB130
Author(s):  
Graham H. Litchman ◽  
Brian Berman ◽  
Roger I. Ceilley ◽  
Clay J. Cockerell ◽  
Laura Ferris ◽  
...  

Author(s):  
Ashley G. Gillman ◽  
Febrio Lunardo ◽  
Joseph Prinable ◽  
Gregg Belous ◽  
Aaron Nicolson ◽  
...  

2021 ◽  
Author(s):  
Sarah VL Hodge ◽  
Beata Mickiewicz ◽  
Matthew Lau ◽  
Craig N Jenne ◽  
Graham C Thompson

Reliable and efficient diagnosis of pediatric appendicitis is essential for the establishment of a clinical management plan and improvement of patient outcomes. Current strategies used to diagnose a child presenting with a suspected appendicitis include laboratory studies, clinical scores and diagnostic imaging. Although these modalities work in conjunction with each other, one optimal diagnostic strategy has yet to be agreed upon. The recent introduction of precision medicine techniques such as genomics, transcriptomics, proteomics and metabolomics has increased both the diagnostic sensitivity and specificity of appendicitis. Using these novel strategies, the integration of precision medicine into clinical practice via point-of-care technologies is a plausible future. These technologies would assist in the screening, diagnosis and prognosis of pediatric appendicitis.


2021 ◽  
Vol 9 (5) ◽  
pp. 1000-1006
Author(s):  
Bhoomika Patel ◽  
Sanjay Srivastava

For effective management of disease, diagnosis and prognosis are two important aspects. Clinical examination is an important tool for assessment of disease as well as condition of patient. Different types of examination depicted in Ayurveda among that Ashtavidha Pariksha viz. Nadi (Pulse), Mootra (Urine), Mala (Faeces), Jihwa (Tongue), Shabda (Speech), Sparsha (Touch), Drika (Eyes) and Akriti (Posture) an effective tool for clinical examination of patient, which was routinely used by traditional Ayurvedic practitioner, but is missing in present era. In this paper, the clinical utility of Ashtavidha Pariksha is discussed which will be helpful for scholars to use it as a diagnostic and therapeutic tool in their clinical practice. Keywords: Ashtasthana Pariksha, Ayurveda, Examination, Diagnosis, Prognosis.


2020 ◽  
Vol 10 (4) ◽  
pp. 1775-1778
Author(s):  
Anouk Tosserams ◽  
Maarten J. Nijkrake ◽  
Ingrid H.W.M. Sturkenboom ◽  
Bastiaan R. Bloem ◽  
Jorik Nonnekes

Compensation strategies are an essential part of managing gait impairments in people with Parkinson’s disease (PD). We conducted an online survey among 320 healthcare professionals with specific expertise in PD management, to evaluate their knowledge of compensation strategies for gait impairments in people with PD, and whether they applied these in daily practice. Only 35% of professionals was aware of all categories of compensation strategies. Importantly, just 23% actually applied all seven available categories of strategies when treating people with PD in clinical practice. We discuss the clinical implications, and provide recommendations to overcome this knowledge gap.


Sign in / Sign up

Export Citation Format

Share Document